Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Gastrooesophageal junction"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alison Bradley, Leo Brown
Publikováno v:
British Journal of Surgery. 108
Aims To assist decision-making by creation of a statistical model that simulates treatment pathways and subsequent outcomes for the management of resectable malignancy of the oesophagus and gastrooesophageal junction. Methods: Discrete Event Simulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6db934c3f4379a921ed1d974e713150
https://doi.org/10.1093/bjs/znab361.121
https://doi.org/10.1093/bjs/znab361.121
Autor:
Leo Brown, Alison Bradley
Publikováno v:
British Journal of Surgery. 108
Aims To perform decision-analysis of treatment options for resectable malignancy of the oesophagus or gastroesophageal junction including: surgery alone, neoadjuvant chemoradiotherapy, neoadjuvant chemotherapy and surgery followed by adjuvant therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e358746a36ca5c915ae3698766fde069
https://doi.org/10.1093/bjs/znab310.005
https://doi.org/10.1093/bjs/znab310.005
Autor:
Georg A. Busslinger, Ingrid A. Franken, Hans Clevers, Michiel F. G. de Maat, Richard van Hillegersberg, Fianne Lissendorp, Jelle P. Ruurda
Publikováno v:
Open Biology, Vol 10, Iss 4 (2020)
Open Biology, 10(4). Royal Society Publishing
Open Biology
Open Biology, 10(4). Royal Society Publishing
Open Biology
The incidence of adenocarcinoma at the gastrooesophageal junction increased over the last years. Curative treatment for patients with upper gastrointestinal (UGI) malignancies, such as oesophageal and gastric tumours, is challenging and requires a mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2d99dfcdd19a8fc58fc8c04b39c1e0b
https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.190274
https://royalsocietypublishing.org/doi/pdf/10.1098/rsob.190274
Publikováno v:
Current Oncology Reports
Survival outcomes following multimodal treatment of operable oesophageal and gastrooesophageal cancer remain disappointingly poor. Although an appreciation of the impact of both tumour location and histological subtype is now shaping the design of cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a277c33419c9ada0dc50081f05a2d5e
https://doi.org/10.1007/s11912-017-0559-8
https://doi.org/10.1007/s11912-017-0559-8
Autor:
Braulio Martínez-Benítez, Enrique Coss-Adame, Samuel Torres-Landa, Edgar Alejandro-Medrano, Gonzalo Torres-Villalobos, Bárbara Ramos-Ávalos, Miguel A. Valdovinos, Janette Furuzawa-Carballeda
Publikováno v:
Case Reports in Gastrointestinal Medicine
Case Reports in Gastrointestinal Medicine, Vol 2016 (2016)
Case Reports in Gastrointestinal Medicine, Vol 2016 (2016)
The aim of the study was to characterize the presence of diverse CD4 and CD8 T cell subsets and regulatory cells in peripheral blood and lower oesophageal sphincter (LES) from a young patient with BE/achalasia without treatment versus achalasia group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3d7b7ac60a110045d39c18cbcbcca26
https://pubmed.ncbi.nlm.nih.gov/27752370
https://pubmed.ncbi.nlm.nih.gov/27752370
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Continuing Education in Anaesthesia Critical Care & Pain. 9:65-69
Over the last two decades, there has been a gradual decline in the number of patients presenting with gastric adenocarcinoma. In 2005, the overall incidence was 9.4 cases per 100 000 population within the UK and 6.4 per 100 000 within Europe; its inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::086e90fb86a1b28d827f85f4105d68f0
https://doi.org/10.1093/bjaceaccp/mkp007
https://doi.org/10.1093/bjaceaccp/mkp007
Publikováno v:
BMC Cancer
Background: Decisions on palliative chemotherapy (CT) for locally advanced or metastatic gastric cancer (mGC) require trade-offs between potential benefits and risks for patients. Healthcare providers and payers agree that patient-preferences should
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a198ab24095504726243a76ff7583cd5
https://pubmed.ncbi.nlm.nih.gov/27923357
https://pubmed.ncbi.nlm.nih.gov/27923357